Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children

Nathan Kuppermann1, Jeanny Park, Kathryn Glatter

  • 1Department of Emergency Medicine, University of California, Davis, School of Medicine, 2315 Stockton Blvd, PSSB Bldg, Ste 2100, Sacramento, CA 95817, USA. nkuppermann@ucdavis.edu

Insights

Diabetic ketoacidosis (DKA) frequently causes prolonged QTc intervals in children, which resolve after recovery. Cardiac monitoring during DKA is crucial, and screening for other ketotic conditions may be beneficial.

Area of Science:

  • Pediatric Cardiology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes mellitus.
  • Ketosis, a metabolic state characterized by elevated ketone bodies, occurs in DKA and other conditions.
  • The cardiac effects of ketosis, particularly QTc interval prolongation, are not well-understood in children.

Purpose of the Study:

  • To investigate the impact of diabetic ketoacidosis (DKA) on the corrected QT (QTc) interval in pediatric patients.
  • To determine the prevalence and characteristics of QTc prolongation during DKA.
  • To assess the correlation between QTc prolongation and clinical variables in children with DKA.

Main Methods:

  • An observational study involving electrocardiography performed during DKA and after recovery in pediatric patients.
  • Measurement of the QTc interval using the Bazett's formula (QT divided by the square root of the RR interval).
  • Correlation analysis of QTc intervals with clinical parameters, including anion gap.

Main Results:

  • The mean QTc interval was significantly higher during DKA (450 ms) compared to after recovery (407 ms) (P < .001).
  • Nearly half of the children (47%) exhibited QTc prolongation during DKA, with a significant decrease post-recovery.
  • The anion gap showed a significant association with QTc prolongation (correlation coefficient, 0.49; P = .006), and electrolyte abnormalities were not the primary cause.

Conclusions:

  • Prolonged QTc intervals are common in children experiencing diabetic ketoacidosis (DKA) and are linked to ketosis.
  • Strict adherence to current cardiac monitoring guidelines for pediatric DKA is recommended.
  • Consideration should be given to electrocardiographic screening for patients with other ketotic conditions.
Abstract

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...